Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study.

Autor: García-García C; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.; Cardiology Department, Heart Institute, Hosptial Universitari Germans Trias i Pujol, Badalona, Spain.; CIBER Enfermedades Cardiovasculares (CIBERCV), Autonomous University of Barcelona, Madrid, Spain., López-Sobrino T; Cardiology Department, Hospital Clínic de Barcelona Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Medical and Translational Research PhD Program, University of Barcelona, Barcelona, Spain., Sanz-Girgas E; Cardiology Department, Hospital Universitari Joan XXIII, Tarragona, Spain., Cueto MR; Cardiology Department, Heart Institute, Hosptial Universitari Germans Trias i Pujol, Badalona, Spain.; Cardiology Department, Hospital Universitari Bellvitge, Barcelona, Spain., Aboal J; Cardiology Department, Hospital Josep Trueta, Girona, Spain., Pastor P; Cardiology Department, Hospital Arnau Vilanova, Lleida, Spain., Buera I; Cardiology Department, Hospital Vall d' Hebrón, Barcelona, Spain., Sionis A; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.; CIBER Enfermedades Cardiovasculares (CIBERCV), Autonomous University of Barcelona, Madrid, Spain.; Intensive Cardiac Care Unit, Cardiology Department, Hospital Santa Creu I Sant Pau, II-B Sant Pau, Barcelona, Spain., Andrea R; Cardiology Department, Hospital Clínic de Barcelona Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Rodríguez-López J; Cardiology Department, Hospital Universitari Joan XXIII, Tarragona, Spain., Sánchez-Salado JC; Cardiology Department, Hospital Universitari Bellvitge, Barcelona, Spain., Tomas C; Cardiology Department, Hospital Arnau Vilanova, Lleida, Spain., Bañeras J; Cardiology Department, Hospital Vall d' Hebrón, Barcelona, Spain., Ariza A; Cardiology Department, Hospital Universitari Bellvitge, Barcelona, Spain., Lupón J; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.; Cardiology Department, Heart Institute, Hosptial Universitari Germans Trias i Pujol, Badalona, Spain.; CIBER Enfermedades Cardiovasculares (CIBERCV), Autonomous University of Barcelona, Madrid, Spain., Bayés-Genís A; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.; Cardiology Department, Heart Institute, Hosptial Universitari Germans Trias i Pujol, Badalona, Spain.; CIBER Enfermedades Cardiovasculares (CIBERCV), Autonomous University of Barcelona, Madrid, Spain., Rueda F; Cardiology Department, Heart Institute, Hosptial Universitari Germans Trias i Pujol, Badalona, Spain.

Publikováno v: ESC heart failure [ESC Heart Fail] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.

Arrhythmic risk stratification in patients with left ventricular ring-like scar.

Autor: Parisi V; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Graziosi M; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Lopes LR; Barts Heart Centre, St Bartholomew's Hospital, London, UK.; Institute of Cardiovascular Science, University College London, London, UK., De Luca A; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy., Pasquale F; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Tini G; Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy., Targetti M; Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy., Cueto MR; Barts Heart Centre, St Bartholomew's Hospital, London, UK.; Heart Failure and Cardiomyopathies Clinic, Germans Trias i Pujol University Hospital, Badalona, Spain., Moura AR; Barts Heart Centre, St Bartholomew's Hospital, London, UK.; Unidade Local de Saúde de Matosinhos, Portugal., Ditaranto R; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Torlasco C; IRCCS, Istituto Auxologico Italiano, Department of Cardiology, Cardiomyopathy Unit, San Luca Hospital, Milan, Italy., Taglieri N; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Nardi E; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Lovato L; Pediatric and Adult Cardio-Thoracic and Vascular, Onco-Hematologic and Emergency Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna., Augusto JB; Institute of Cardiovascular Science, University College London, London, UK.; Cardiology Department, Hospital Prof Doutor Fernando Fonseca, Amadora, Portugal.; Católica Medical School, Universidade Católica Portuguesa, Lisbon, Portugal., Galiè N; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Crotti L; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.; IRCCS, Istituto Auxologico Italiano, Department of Cardiology, Cardiomyopathy Unit, San Luca Hospital, Milan, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Gasperetti A; Division of Cardiology, School of Medicine, Johns Hopkins University, 600 N. Wolfe St. Blalock 545, Baltimore, MD 21287, USA., Biffi M; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart., Autore C; Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Rome, Italy., Merlo M; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy., Olivotto I; Meyer Children Hospital and Careggi University Hospital, University of Florence, Florence, Italy., Sinagra G; Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina and University of Trieste, Trieste, Italy., Elliott PM; Barts Heart Centre, St Bartholomew's Hospital, London, UK.; Institute of Cardiovascular Science, University College London, London, UK., Biagini E; Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Nov 01. Date of Electronic Publication: 2024 Nov 01.

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

Autor: Araujo-Castro M; Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS)., Madrid, Spain. marta.araujo@salud.madrid.org., Ruiz-Sánchez JG; Endocrinology & Nutrition Department. Hospital Universitario Fundación Jiménez Díaz, Health Research Institute-Fundación Jiménez Díaz University Hospital (IIS-FJD, UAM), Madrid, Spain., Parra Ramírez P; Endocrinology & Nutrition Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Martín Rojas-Marcos P; Endocrinology & Nutrition Department, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain., Aguilera-Saborido A; Cardiology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Gómez Cerezo JF; Internal Medicine, Hospital Universitario Infanta Sofía. Universidad Europea de Madrid, Madrid, Spain., López Lazareno N; Biochemical Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Torregrosa Quesada ME; Biochemical Department, Hospital General Universitario Dr. Balmis de Alicante, Alicante, Spain., Gorrin Ramos J; Biochemical department, Laboratori de Referència de Catalunya, Barcelona, Spain., Oriola J; Biochemistry and Molecular Genetics Department, CDB. Hospital Clínic. University of Barcelona, Barcelona, Spain., Poch E; Nephrology Department. Hospital Clinic, IDIBAPS. University of Barcelona, Barcelona, Spain., Oliveras A; Nephrology Department. Hospital del Mar, Universitat Pompeu Fabra, Barcelona, ES, Spain., Méndez Monter JV; Vascular and Interventional Radiology Department, Hospital Clínico San Carlos, Madrid, Spain., Gómez Muriel I; Radiology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Bella-Cueto MR; Pathology Department, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA). Universitat Autònoma de Barcelona. Sabadell, Barcelona, Spain., Mercader Cidoncha E; General Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Fellow European Board of Surgery -Endocrine Surgery, Madrid, Spain., Runkle I; Endocrinology and Nutrition Department, Hospital Clínico San Carlos, Madrid, Spain., Hanzu FA; Endocrinology & Nutrition Department, Hospital Clinic. IDIBAPS. University of Barcelona, Barcelona, Spain. fhanzu@clinic.cat.

Publikováno v: Endocrine [Endocrine] 2024 Jul; Vol. 85 (1), pp. 99-121. Date of Electronic Publication: 2024 Mar 06.

Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.

Autor: Mazarico-Altisent I; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain. isamazarico@gmail.com., Capel I; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Baena N; Genetic Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Bella-Cueto MR; Pathology Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Barcons S; Surgery Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Guirao X; Surgery Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Albert L; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Cano A; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Pareja R; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Caixàs A; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain., Rigla M; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT), Medicine Department, Universitat Autònoma de Barcelona, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain.

Publikováno v: Journal of endocrinological investigation [J Endocrinol Invest] 2023 Apr; Vol. 46 (4), pp. 829-840. Date of Electronic Publication: 2022 Nov 05.

Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.

Autor: Póvoa AA; Department of General Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), 4434-502 Vila Nova de Gaia, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal., Teixeira E; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal., Bella-Cueto MR; Department of Pathology, Parc Taulí Sabadell Hospital Universitari-Institut d'Investigació i Innovació Parc Taulí-I3PT-Universitat Autònoma de Barcelona, 08208 Barcelona, Spain., Batista R; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal., Pestana A; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal., Melo M; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Department of Endocrinology, Centro Hospitalar Universitário de Coimbra,3000-075 Coimbra, Portugal., Alves T; Laboratório de Endocrinologia Molecular e Translacional-Departamento de Medicina, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil., Pinto M; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal., Sobrinho-Simões M; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal., Maciel J; Department of General Surgery, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), 4434-502 Vila Nova de Gaia, Portugal.; Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, 4200-253 Porto, Portugal., Soares P; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, 4200-135 Porto, Portugal.; Cancer Signaling and Metabolism, i3S-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.; Departament of Pathology, Faculdade de Medicina da Universidade do Porto, 4200-319, Porto, Portugal.

Publikováno v: Cancers [Cancers (Basel)] 2021 Apr 23; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 23.